Zelboraf 240mg, Vemurafenib, Melanoma Treatment, Cancer Therapy, ZarvyPharm
AntiCancer Drugs Skin Cancer

Zelboraf 240mg - 56 Tablets

★★★★★
★★★★★
4.8

(5)

Drug Type Original
Active Ingredient VEMURAFENIB
Strength 240MG
Manufacturer ROCHE
Zelboraf 240mg 56 Tablets front box packaging
Zelboraf 240mg 56 Tablets blister strip close-up
Zelboraf 240mg 56 Tablets box with outer carton
Zelboraf 240mg 56 Tablets front box packaging
Zelboraf 240mg 56 Tablets blister strip close-up
Zelboraf 240mg 56 Tablets box with outer carton
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 56 TABLETS $ 26.61 $ 1,489.90
$ 1,266.42
Apply ZARVY26 (-15%)
You save $ 223.49
2 BOXES - 112 TABLETS $ 26.27
1% $ 2,979.80
$ 2,941.90
$ 2,500.62
Apply ZARVY26 (-15%)
You save $ 441.29
★ Best Value 4 BOXES - 224 TABLETS $ 25.86
3% $ 5,959.60
$ 5,791.90
$ 4,923.12
Apply ZARVY26 (-15%)
You save $ 868.79

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Zelboraf 240mg is an oral targeted therapy formulated for patients with BRAF V600 mutation-positive cancers. As a selective BRAF kinase inhibitor, it blocks aberrant MAPK signaling in tumor cells harboring the V600E mutation. It was one of the first drugs approved specifically for BRAF-mutant metastatic melanoma and remains a critical agent in precision oncology. The 240mg film-coated tablets are administered twice daily and often used until progression or the onset of significant toxicity. Zelboraf has also gained off-label recognition for conditions like Erdheim-Chester Disease and rare BRAF-driven solid tumors.

Indications & Uses

- AntiCancer Drugs > Skin Cancer (Metastatic Melanoma) Zelboraf is FDA-approved for the treatment of unresectable or metastatic melanoma in adults with confirmed BRAF V600E mutation. It improves progression-free and overall survival, particularly in patients not previously treated with immune checkpoint inhibitors. > Others (Histiocytosis Erdheim-Chester Disease) Used in adult patients with Erdheim-Chester Disease (ECD) harboring a BRAF V600 mutation. Although a rare hematologic neoplasm, ECD responds well to BRAF inhibition due to its oncogenic driver mutation.

Benefits & Effectiveness

Vemurafenib selectively targets the BRAF V600E kinase, an aberrant driver of MAPK signaling in tumor cells. By inhibiting this pathway, the drug blocks tumor proliferation and promotes apoptosis. It does not affect wild-type BRAF, making it suitable only for patients confirmed to carry the V600E mutation. The therapeutic action results in rapid tumor shrinkage, improved survival rates, and symptom control, especially in aggressive metastatic melanoma.

Directions for Use

All patients must be tested and confirmed positive for the BRAF V600E mutation via an FDA-approved diagnostic test before initiating therapy. - Metastatic Melanoma: • 960 mg orally every 12 hours (total 1920 mg/day) • Continue until disease progression or unacceptable toxicity • Tablets may be taken with or without food • Do not crush or split the tablets - Histiocytosis (Erdheim-Chester Disease): • Same dosing: 960 mg orally every 12 hours • Duration based on response and tolerability • Monitor cardiac function, dermatologic adverse events, and liver enzymes [Administration Tips] - Tablets should be swallowed whole with water - If a dose is missed, it should not be taken if more than 4 hours have passed - Dose adjustments may be required based on liver toxicity or QT prolongation

Storage

Store at 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C. Keep in original packaging to protect from moisture. Avoid exposure to excessive heat or sunlight.

Possible Side Effects

Common adverse effects include arthralgia, rash, photosensitivity, fatigue, and alopecia. Serious reactions may include cutaneous squamous cell carcinoma (cuSCC), hepatotoxicity, QT prolongation, and hypersensitivity reactions. Dermatologic monitoring is required during therapy. Regular ECGs and liver function tests are recommended. Dose interruption or reduction may be necessary in case of grade 3–4 toxicity.

FAQs

No, only for those who test positive for the BRAF V600E mutation using an FDA-approved diagnostic test.
Yes, it has been used off-label for Erdheim-Chester Disease and is being explored for other BRAF-driven tumors.
Many patients show tumor shrinkage within weeks, though full response may take longer.
Yes, in some cases, Zelboraf is combined with MEK inhibitors to reduce resistance and enhance outcomes.
Skip the missed dose if more than 4 hours have passed; do not double-dose.

Ratings & Reviews

Reviewed by 5 Users

4.8/5
★★★★★
★★★★★
5★
80%
4★
20%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

Product
D**d L*e Jan 20, 2024
★★★★★
★★★★★

Secure Packaging

The vial arrived in perfect condition in a temperature-controlled pack. Appreciate the attention to detail for sensitive medication.

Product
E**y W**e Sep 05, 2023
★★★★★
★★★★★

Reliable service and clear communication

Received tracking updates throughout the process. The customer support team clarified my questions about insurance coverage promptly.

Product
K**i T**a Jun 22, 2023
★★★★★
★★★★★

丁寧な梱包と迅速な対応

注文から発送までスムーズでした。特に医薬品の梱包がしっかりしていて安心できました。

Product
M**k J**n Mar 15, 2023
★★★★★
★★★★★

Fast Delivery for Essential Medication

The order arrived much faster than anticipated. Packaging was secure and discreet.

Product
J**a C**n Nov 10, 2022
★★★★★
★★★★★

Easy Prescription Verification

The online portal made uploading and verifying the prescription simple. Relieved to have found a dependable source.

Alternatives

Combo Deals

No combo deals available at the moment.